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Abstract
Introduction. Churg-Strauss syndrome (CSS) is an allergic
granulomatous angiitis, a rare disease of small and medium ar-
teries and veins, associated with the presence of perinuclear
antineutrophil cytoplasmic antibodies (p-ANCA). According to
the American College of Rheumatology (ACR), there are four
or more criteria out of six for the diagnosis: asthma, eosino-
philia (> 10% in peripheral blood), paranasal sinusitis, pulmo-
nary infiltrates, histological evidence of vasculitis with extravas-
cular eosinophils, and mononeuritis multiplex or polyneu-
ropathy. Case report. We reported a female patient, aged 80
years, with asthma for many decades and repeatedly verified
eosinophilia in peripheral blood, in which CSS was suspected
only after the occurrence of skin changes in the form of vesi-
cles, vesiculopustule, purpuric macula, papule and petechiae.
Further tests verified pulmonary infiltrates, paranasal sinusitis,
extravascular eosinophils on histopathologic sample of skin tis-
sue, and polyneuropathy. The treatment started with methyl-
prednisolone (60 mg/d, with decreasing doses), and continued
with pulse doses of cyclophosphamide (800 mg once monthly),
also corticosteroid ointment for skin lesions. Conclusion. De-
spite long-standing pulmonary symptoms and laboratory find-
ings of eosinophilia, the appearance of skin changes raised sus-
picion of possible CSS. Skin changes resolved and the patient
was reffered to rheumatologist.
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Apstrakt
Uvod. Churg-Strauss sindrom (CSS) predstavlja alergijski gra-
nulomatozni angiitis. To je retko oboljenje, koje zahvata male i
srednje arterije i vene i povezano je sa prisustvom perinuklear-
nog antineutrofilnog citoplazmatskog antitela (p-ANCA). Pre-
ma Ameriÿkom koledžu za reumatologiju (ACR), potrebno je
ÿetiri ili više  kriterijuma od ukupno šest za postavljanje dijag-
noze CSS: astma, eozinofilija (> 10% u perifernoj krvi), para-
nazalni sinuzitis, pluýni infiltrati, histološki dokaz vaskulitisa sa
ekstravaskularnim eozinofilima i mononeuritis multiplex ili poline-
uropatija. Prikaz bolesnika. Prikazali smo bolesnicu staru 80
godina, sa višedecenijskom astmom i eozinofilijom verifikova-
nom u više navrata, kod koje je postavljena sumnja na ovo re-
umatološko oboljenje tek posle pojave promena na koži u vidu
vezikula, vezikulopustula, purpuriÿnih makula, papula i petehi-
ja. Daljim pretragama verifikovani su i pluýni infiltrati, parana-
zalni sinuzitis, ekstravaskularni eozinofili na histopatološkom
uzorku tkiva kože, kao i polineuropatija. Leÿenje je zapoÿeto
metilprednizolonom (60 mg dnevno, sa opadanjem doze), a na-
stavljeno pulsnim dozama ciklofosfamida (800 mg meseÿno),
uz kortikosteroidnu mast za lezije na koži. Zakljuÿak. Uprkos
dugogodišnjim simptomima pluýnog oboljenja i eozonofiliji,
tek je sa pojavom promena na koži posumnjano na CSS. Pro-
mene su se povukle, a bolesnica je nastavila leÿenje kod reu-
matologa.
Kljuÿne reÿi:
angiitis, alergijski, granulomatozni; dijagnoza; koža,
bolesti; histološke tehnike.
Introduction
Churg-Strauss syndrome (CSS) is a systemic vasculitis
involving small vessels, affecting several organs. Asthma is
usually the first clinical sign of CSS. It is often accompanied
by allergic rhinitis and sinusitis. CSS progress to peripheral
and tissue eosinophilia, eventualy resulting in necrotizing vas-
culitis with extravascular granulomas. About 60% of CSS pa-
tients have skin lesions in the active phase of the disease, but
the skin lesions  may appear also in its early stage. Most com-
mon are palpable purpura and nodules, usually located on the
limbs and scalp. Less usual skin features are livedo reticularis,
vesicles, aseptic pustules, ecchymoses and urticarial wheals 
1.
Also  maculopapular erythematous eruption resembling ery-
thema multiforme has been described 
2. Papular and nodular
lesions may turn in necrotic-ulcerative evolution 
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features  can appear at the same time or in  the different stages
of CSS. Histopathology examination reveals a leukocytoclastic
vasculitis, commonly  involving venules; sometimes, the ves-
sel wall reveals fibrinoid changes surrounded by granuloma-
tous inflammation; finding  of numerous eosinophils in the in-
filtrate,  in addition to  neutrophils, lymphocytes and  macro-
phages, is of diagnostic importance 
1. We presented a female
patient with suspected CSS due to cutaneous features which
corresponded to lesions described in the  literature. It was con-
firmed by histopathologic report.
Case report
A 80-year-old female was admitted to hospital with few
vesicles, vesiculopustules, purpuric maculas, papules and
petechiae on the skin of her hands, feet, extremities and trunk
(Figures 1, 2 and 3). Skin changes occured a year and a half
before, with fatigue and weight loss (about 10 kg of body
weight), without neurological and other symptomatology.
Data from the personal history revealed repeated eosino-
philia in recent decades; diagnosed bronchial asthma was
treated with beclomethasone, salbutamol and salmeterol xi-
nafoate inhalation powder; arterial  hypertension was not
regularly treated.
Fig. 1 – Purpuric macules and papules on the lower back.
Fig. 2 – Vesicles, vesiculopustules, petechiae and purpuric
maculas on the dorsal hand.
Fig. 3 – Vesicles, vesiculopustules, petechiae and purpuric
maculas of the hand.
On admission, laboratory analyses revealed increased
erythrocyte sedimentation rate (ESR) (54 mm/h), fibrinogen
6.83 g/L; eosinophilia 45.8% was evident (with normal count
of leukocytes 9.57 u 10
9/L), with relative neutropenia 31.4%,
lymphopenia 14.5%, as well as elevated rheumatoid factor of
66.4 U/L and increased immunoglobulin (Ig)E concentration
741 IU/L. Other complete blood count parameters, electro-
lytes, urea, creatinine, total bilirubine, creatine phosphokinase,
protein electrophoresis, aspartate aminotransferase (AST), ala-
nine aminotransferase (ALT), gama-glutamyl transferase
(ȖGT), IgG, IgA, IgM, C3 and C4 were within normal range.
Urinalysis was normal. ELISA test for echinococcus, toxocara,
HIV, HBsAg and HCV tests were negative. Other infective
causes of eosinophilia were also ruled out [stool sample test
for intestinal parasites and Strongyloides stercoralis, sputum
for acido-resistance bacilli (ARB) direct examination and
Löwenstein cultivation]. In peripheral blood smear increased
number of leukocytes was evident (11.7 u 10
9/L), as well as
elevated percentage of eosinophiles (61%). The concentration
of proteins in 24-h urine (Biuret method, in 3 times) was nor-
mal; albumin in 24-h urine: normal findings. Antinuclear anti-
bodies (ANA) (tissue-type substrate) +1 : 10; perinuclear anti-
neutrophil cytoplasmic antibodies (p-ANCA), cytoplasmic an-
tineutrophil cytoplasmic antibodies (c-ANCA) and anticardio-
lipin antibodies (ACA) within the physiologic range. Autoan-
tibodies against basement membrane zone (ABMZ) were not
detected. Lung function test: normal spirometry finding, trans-
fer factor for carbon monoxide (CO) and transfer coefficient
were slightly reduced; oxygen saturation was 96%.
Multislice scanning (MSCT) of the chest revealed
changes of partly honeycomb appearance in the lungs
bilaterally and in the upper and lower lobe, in favor of fibro-
sis, in particular mediastinal lymph nodes up to 1 cm in di-
ameter at the level of tracheal carina in the right hilus and
below the aortic arch (Figure 4). Bronchoscopy was planned
but refused by the patient. Radiologic (X-ray) findings on
paranasal sinuses revealed thickened lining of the left frontal
and maxillary sinuses (Figure 5). Ultrasound examination of
the heart, abdomen and pelvis revealed normal findings.Strana 702 VOJNOSANITETSKI PREGLED Volumen 70, Broj 7
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Fig. 4 – Multislice scanning of the chest revealed honeycomb
lungs in favor of fibrosis.
Fig. 5 – X-ray finding of paranasal sinuses showed thickened
lining of the left frontal and maxillary sinuses.
Skin biopsy was taken and histopathologic analysis re-
vealed infiltrate of lymphocytes,  many neutrophils and eo-
sinophils around capillaries and collagen fibers between the
upper dermis,  with clustered eosinophils at some places; the
presence of cariorexic debri and  fresh erythrocytes extrava-
sated; periodic acid schiff (PAS) staining revealed segments
of the microvascular wall space with fibrinoid necrosis (Fig-
ure 6a and b). Deposits of immunoreactants were not found
on direct immunofluorescence (DIF) examination of the skin
specimen. Neurologic examination revealed sensorimotor
neuropathy.
Considering the changes in the lungs, asthma, hypero-
esinophilia, thickened mucosa of frontal sinus and sensori-
motor neuropathy (consulted specialists were rheumatologist,
neurologist, pulmologist, otolaryngologist, hematologist and
infectologist) diagnosis of CSS was established and the ther-
apy with methylprednisolone (60 mg daily iv, with decreas-
ing doses), pulse dose of cyclophosphamide (800 mg) once
monthly, was started, with vitamine B complex and tocoph-
erol recommended by neurologist, bronchodilators recom-
mended by pulmologist and local therapy with momethasone
furoat 0.1% ointment once daily until skin changes resolved;
then the patient was reffered to the rheumatologist.
Discussion
Churg and Strauss first described this disorder in 1951
when they reviewed 13 autopsy cases that were previously
classified as polyarteritis nodosa. These cases were atypical
in that asthma and eosinophilia preceded the systemic vascu-
litis. They named the syndrome “allergic angiitis and allergic
granulomatosis”, also known as CSS 
4.
 CSS is an allergic
granulomatous angiitis: a very rare disease of small and me-
dium arteries and veins, associated with p-ANCA 
5, 6. p-
ANCA directed predominantly against a myeloperoxidase
was initially reported in as many as 75–80% of patients with
CSS, but in one study showed that only 13% had positive p-
ANCA findings. Allergic granulomatosis and angiitis is a
disorder characterized by extravascular  granulomas, hy-
pereosinophilia, and pulmonary and systemic small-vessel
vasculitis. The American College of Rheumatology (ACR)
has proposed 6 criteria  for the diagnosis of CSS 
7. The pres-
ence of 4 or more criteria are enough for diagnosing CSS.
These criteria include: asthma, eosinophilia (> 10% in pe-
ripheral blood), paranasal sinusitis, pulmonary infiltrates,
histological  evidence of vasculitis with extravascular eo-
sinophils, and mononeuritis multiplex or polyneuropathy.
The differential diagnosis of CSS includes at first place dis-
eases associated with pulmonary infiltrates and eosinophilia
(eosinophilic pneumonia, eosinophilic granuloma, infections
and Wegener granulomatosis). Corticosteroids are the main-
stay of treatment in CSS. The addition of other medications
a) b)
Fig. 6 – Periodic acid schift (PAS) staining showed segments of the microvascular wall space with fibrinoid necrosis
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(cytotoxic agents) may be necessary in cases of life- or or-
gan-threatening vasculitis. The survival rate of CSS ranges
from 68% to 100% at 5 years 
8.
Cutaneous findings occur in 60% of CSS patients, and
include palpable purpura, subcutaneous nodules (typically on
the scalp or extremities), and less often, vesicles, urticaria,
livedo reticularis, retiform purpura and papulonecrotic le-
sions 
9. They usually present on the limb surfaces, but can af-
fect any part of the body. In our patient, few vesicles,
vesiculopustules, purpuric macules, papules and petechiae on
the skin of her hands, feet, extremities and trunk were found.
In differential diagnosis autoimmune bullous dermatosis was
observed, but immunopathology test did not aprrove it. Also,
in hypereosinophilic syndrome, skin pattern is angioedema-
tous with urticaria and dermographismus, erythematous pru-
ritic papules, plaques and nodules, less common erythro-
derma and erythema annulare, but skin changes and thick-
ened mucosa of frontal sinus of our patient with the absence
of severe cardiac and neurologic manifestations (embolic or
thrombotic), which are usual in primary hypereosinophilic
syndrome, made clinical distinction. In our patient, skin
changes were insufficient for making diagnosis by clinical
examination, but histopathologic finding of skin specimen
with perivascular eosinophils confirmed diagnosis of CSS
cutaneous manifestation. The changes in the lungs, asthma,
hypereosinophilia, thickened mucosa of frontal sinus, senso-
rimotor neuropathy and skin lesions established diagnosis of
CSS.
Conclusion
Despite long-standing pulmonary symptoms and labo-
ratory findings of eosinophilia, the appearance of skin
changes raised suspicion of possible CSS.  Skin changes cor-
respond to changes in this syndrome have been described in
the literature.
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